Review




Structured Review

Takeda aro-aat
Aro Aat, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aro-aat/aro+aat/pm40388610-511-11-21
Average 90 stars, based on 1 article reviews
aro-aat - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

Infection:

Article Title: Hepatocyte targeting via the asialoglycoprotein receptor
Article Snippet: 10 , Fazirsiran, ARO-AAT, TAK-999 , Arrowhead†/Takeda‡ , α1 antitrypsin deficiency associated liver disease (AATD) , Alpha-1 antitrypsin (AAT) , Phase III , 28 studies reported , , Lit. .

Article Title: Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
Article Snippet: Arrowhead/Takeda , ARO-AAT , Phase 2/3 , siRNA/GalNAc conjugate , Mutant α-1 antitrypsin (Z-AAT) protein , α-1 Antitrypsin deficiency (AATD).

Article Title: Framework to identify innovative sources of value creation from platform technologies.
Article Snippet: Takeda, Takeda and Arrowhead collaborate to co- develop and co- commercialize ARO- AAT for alpha- 1 antitrypsin- associated liver disease (2020). https://www.takeda.com/newsroom/ newsreleases/2020/takeda- and- arrowhead- collaborate- to- co- develop- and- co- commercialize- aroaat- foralpha- 1- antitrypsin- associated- liver- disease/.

Article Title: Ingredient makers shrink sugar in yogurt
Article Snippet: ▸ Barentz International will buy Maroon Group, a rival distributor of chemicals and life sciences ingredients, for an undisclosed sum.. Based in Avon, Ohio, Maroon has about 300 employees and annual sales of $500 million.. ▸ BASF says it will close a glufosinate facility in Muskegon, Michigan, and one plant in Knapsack, Germany, by 2022, a move that affects 100 jobs.

Coagulation:

Article Title: Hepatocyte targeting via the asialoglycoprotein receptor
Article Snippet: 10 , Fazirsiran, ARO-AAT, TAK-999 , Arrowhead†/Takeda‡ , α1 antitrypsin deficiency associated liver disease (AATD) , Alpha-1 antitrypsin (AAT) , Phase III , 28 studies reported , , Lit. .

Article Title: Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
Article Snippet: Arrowhead/Takeda , ARO-AAT , Phase 2/3 , siRNA/GalNAc conjugate , Mutant α-1 antitrypsin (Z-AAT) protein , α-1 Antitrypsin deficiency (AATD).

Article Title: Framework to identify innovative sources of value creation from platform technologies.
Article Snippet: Takeda, Takeda and Arrowhead collaborate to co- develop and co- commercialize ARO- AAT for alpha- 1 antitrypsin- associated liver disease (2020). https://www.takeda.com/newsroom/ newsreleases/2020/takeda- and- arrowhead- collaborate- to- co- develop- and- co- commercialize- aroaat- foralpha- 1- antitrypsin- associated- liver- disease/.

Article Title: Ingredient makers shrink sugar in yogurt
Article Snippet: ▸ Barentz International will buy Maroon Group, a rival distributor of chemicals and life sciences ingredients, for an undisclosed sum.. Based in Avon, Ohio, Maroon has about 300 employees and annual sales of $500 million.. ▸ BASF says it will close a glufosinate facility in Muskegon, Michigan, and one plant in Knapsack, Germany, by 2022, a move that affects 100 jobs.



Similar Products

90
Takeda aro-aat
Aro Aat, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aro-aat/aro+aat/pm40388610-511-11-21
Average 90 stars, based on 1 article reviews
aro-aat - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Arrowhead Pharmaceuticals aro-aat
Aro Aat, supplied by Arrowhead Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aro-aat/aro+aat/pmc11609720-414-0-1
Average 90 stars, based on 1 article reviews
aro-aat - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

86
Arrowhead Pharmaceuticals aro aat 249
Aro Aat 249, supplied by Arrowhead Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aro-aat/249+aat+aro/pmc10861989-1103-0-22
Average 86 stars, based on 1 article reviews
aro aat 249 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
Arrowhead Pharmaceuticals fazirsiran aro-aat/tak 999
Approved and under trial siRNA therapeutics for different diseases.
Fazirsiran Aro Aat/Tak 999, supplied by Arrowhead Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aro-aat/fazirsiran+aro+aat+tak+999/pmc09939533-53-0-4
Average 90 stars, based on 1 article reviews
fazirsiran aro-aat/tak 999 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Arrowhead Pharmaceuticals sirna aro-aat
Approved and under trial siRNA therapeutics for different diseases.
Sirna Aro Aat, supplied by Arrowhead Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aro-aat/aro+ang3/pmc09275120-74-2-4
Average 90 stars, based on 1 article reviews
sirna aro-aat - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Approved and under trial siRNA therapeutics for different diseases.

Journal: Frontiers in Bioengineering and Biotechnology

Article Title: Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery

doi: 10.3389/fbioe.2023.1112755

Figure Lengend Snippet: Approved and under trial siRNA therapeutics for different diseases.

Article Snippet: Fazirsiran (ARO-AAT/TAK 999) , Arrowhead Pharmaceuticals and Takeda , Liver disease associated with α-1 antitrypsin deficiency (AATD) , Mutant α-1 antitrypsin (Z-AAT) , GalNAc , - , (NCT03945292) .

Techniques: Mutagenesis, Virus, Infection